Source: Clinics. Conference titles: Simpósio avanços em pesquisas médicas. Unidade: FM
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE (TERAPIA), ANTIDIABÉTICOS (HIPOGLICEMIANTES) (APLICAÇÕES TERAPÊUTICAS), RESUMOS (SIMPÓSIOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUNHA, M. R. et al. Lower post prandial glucose excursion and better lipid contrl by treatment with metformin/glibenclamide combination tablet (Glucovance®) in comparison to metformin + glibenclamide coadministered separately to patients with type 2 diabetes (DM2). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 09 nov. 2024. , 2007APA
Cunha, M. R., Silva, M. E. R., Santos, R. F., Fukui, R. T., Correia, M. R. S., Wajchenberg, B. L., et al. (2007). Lower post prandial glucose excursion and better lipid contrl by treatment with metformin/glibenclamide combination tablet (Glucovance®) in comparison to metformin + glibenclamide coadministered separately to patients with type 2 diabetes (DM2). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.NLM
Cunha MR, Silva MER, Santos RF, Fukui RT, Correia MRS, Wajchenberg BL, Ursich MJM, Rocha DM. Lower post prandial glucose excursion and better lipid contrl by treatment with metformin/glibenclamide combination tablet (Glucovance®) in comparison to metformin + glibenclamide coadministered separately to patients with type 2 diabetes (DM2). Clinics. 2007 ; 62 S89.[citado 2024 nov. 09 ]Vancouver
Cunha MR, Silva MER, Santos RF, Fukui RT, Correia MRS, Wajchenberg BL, Ursich MJM, Rocha DM. Lower post prandial glucose excursion and better lipid contrl by treatment with metformin/glibenclamide combination tablet (Glucovance®) in comparison to metformin + glibenclamide coadministered separately to patients with type 2 diabetes (DM2). Clinics. 2007 ; 62 S89.[citado 2024 nov. 09 ]
